-
公开(公告)号:US20220144941A1
公开(公告)日:2022-05-12
申请号:US17286247
申请日:2019-10-16
Applicant: UCB BIOPHARMA SRL
Inventor: Melissa Kaye Brock , William James Byrnes , Bernhard Heinrich Greve , Claus Peter Kiessling , Grant Langdon , Elizabeth Webster Manis
IPC: C07K16/28 , A61K39/395 , A61P21/04
Abstract: The disclosure relates to a method of treating or preventing Myasthenia Gravis (MG) in a human in need thereof using an anti-FcRn antibody or antigen binding fragment thereof. In particular, the method provides suitable dosage regimens for such treatment.